Sponsor Co-Investment: How Much Skin in the Game Is Enough?

Why This Number Matters More Than the Projected IRR

Every pitch deck has a slide claiming the sponsor is "heavily invested alongside our LPs." The specific dollar figure is almost never on that slide. When it is, the calculation behind it often includes things we would not count as real capital at risk.

Sponsor co-investment is one of the few LP-facing numbers that genuinely predicts sponsor behavior. The projected IRR is an opinion. The preferred return is a promise. The co-investment is cash the sponsor has actually wired into the deal and cannot pull out without a liquidity event. Everything else in the offering is commentary.

The question most LPs ask is "how much is the GP putting in?" The better question is "how much is the GP putting in, on what terms, from what source, and at what percentage of their personal net worth?" Those four filters change the answer dramatically.

This post walks through what meaningful co-investment actually looks like, how to read between the lines of the offering documents, and the minimum thresholds I use when evaluating a deal. If you have been through our broader post on GP-LP alignment, think of this as the deep dive on the single most important alignment signal.

The Headline Number vs. the Real Number

Sponsors describe their co-investment in different ways. Not all of them mean the same thing.

What gets counted in the pitch

Most commonly you will see one of the following structures on the GP commitment slide:

• A dollar amount. "The sponsor team is investing $500,000 alongside LPs."
• A percentage of total equity. "The GP is contributing 5% of the equity raise."
• A percentage of the deal size. "The sponsor has 2% of the purchase price committed."

Three different framings, three different bases. A $500,000 GP commitment on a $10 million equity raise is 5%. That same $500,000 on a $40 million deal with $13 million of equity is less than 4%. The percentage of purchase price dilutes further once leverage is included. Read the base.

What often gets counted but probably should not

There are a few patterns that inflate the stated co-investment without putting any new capital at risk:

• Waived acquisition fees rolled in as equity. A sponsor who waives a $300,000 acquisition fee and calls it equity is not writing a check. The money would have flowed to them at closing if they had not waived it. That is an opportunity cost, not an investment.
• Deferred fees treated as equity. Same principle. A deferred asset management fee that converts to equity is future compensation repriced as present investment. It is not the same thing as wiring cash.
• Promote conversion to LP units. Some sponsors take a smaller promote in exchange for LP-class equity. That is a fair trade and not nothing, but it is not personal capital at risk.
• Commitments funded from the current deal's fees. In a fund-of-funds or serial syndicator structure, the GP's "equity" on deal #3 might come from fee income earned on deals #1 and #2. That recycled fee income is real money, but the sponsor has not taken a personal drawdown to fund it.

The common fix: ask the sponsor to break the co-investment into "personal after-tax capital" vs. "waived or deferred fees." Most will give you an honest answer when asked directly. The ones who cannot are telling you something.

A worked example

Suppose the offering memorandum says the sponsor is investing $1.0 million into a $12 million equity raise. That is 8.3% on the surface — a strong number.

Now read the footnote. It turns out:

• $400,000 is a waived acquisition fee
• $300,000 is a deferred asset management fee that will convert to equity over the first three years of operations
• $300,000 is personal cash from the sponsor principals

The real co-investment is $300,000, or 2.5% of the equity raise. That is a different deal. The waived and deferred components are not zero — they do reduce the fee load, which matters — but they do not belong in the co-investment number.

Minimum Thresholds I Use

There is no single right number. Co-investment needs should scale with deal complexity, the sponsor's track record, and whether we are in a fund or single-asset deal. The following are rough thresholds I apply as a starting point.

Single-asset syndications

For a single-asset deal in a familiar asset class (stabilized multifamily, small-format industrial, self-storage), I want to see:

• 5% of total equity raised as a soft minimum for established sponsors
• 7% to 10% for first-time or early-career sponsors where the track record does not yet support trust
• 1% to 3% is a flag that should trigger more questions — it does not automatically disqualify, but it shifts the burden of proof

In value-add or development deals, the complexity argues for more co-investment rather than less. If the sponsor is asking LPs to underwrite construction risk, lease-up risk, and execution risk, they should be taking a proportional share of that risk personally.

Real estate funds

Fund vehicles typically have lower GP commitments as a percentage because the absolute dollars are larger. A 2% GP commit on a $200 million fund is $4 million — the same absolute dollars as a 5% commit on a $80 million deal.

For a discretionary fund, I look for:

• 2% to 3% GP commitment from institutional-style sponsors
• The commitment should be funded at the start, not called pro rata alongside LP calls (LPs-first capital calls are a red flag)
• Side-letter carve-outs for the GP commitment should be disclosed — some funds reduce the effective GP commit through management company subsidies

As a percentage of sponsor personal net worth

This is the question most LPs are too polite to ask, but it is the most revealing one. A sponsor investing $500,000 in a deal looks different if they have a $5 million net worth versus a $50 million net worth. In the first case it is 10% of liquid capital. In the second case it is 1%.

I am not suggesting LPs audit their sponsor's personal balance sheet — that is neither appropriate nor realistic. But an open conversation about how the deal compares to their other current commitments is reasonable. The answers usually sort sponsors into two groups: those who talk about their investment as a meaningful personal allocation, and those who treat it as a marketing checkbox.

Why Co-Investment Shapes GP Behavior

The reason co-investment matters is not symbolic. It changes the sponsor's decision-making during the hold period, especially at inflection points.

Reserves and operating discipline

A sponsor with meaningful capital in the deal is more likely to hold adequate operating reserves rather than minimizing them to show higher projected returns. Their downside is real. Under-reserving to juice a pitch becomes less attractive when they personally eat the consequences.

Hold-period decisions

At the 24-month or 36-month mark, every value-add deal faces a decision: refinance and hold, sell now, or keep executing the business plan. A sponsor whose compensation is heavily weighted toward the promote may prefer to sell early. A sponsor with meaningful personal capital in the deal is more likely to optimize for total dollars returned rather than a quick IRR-maximizing exit. This matters because IRR-maximized exits often leave equity multiple on the table.

Capital call decisions

When a deal runs into trouble and needs additional capital, the sponsor has to choose between asking LPs for more money, bringing in preferred equity or rescue capital, or deferring/waiving fees. A sponsor with real skin in the game is more likely to absorb some of the pain rather than push all of it to LPs. If you have ever been through a capital call on a deal where the GP had no personal capital at risk, you already understand this.

Communication during bad quarters

This one is less measurable, but it is real. Sponsors with their own capital at risk tend to communicate more candidly during difficult periods. The deal is their problem, not just an asset management assignment. The quality of quarterly reporting tends to track with the GP's own exposure.

How to Verify What You Are Told

A number on a pitch slide is not the same as a number in the operating agreement.

The paper trail

• The operating agreement should specify the GP's capital contribution in dollars. This is the enforceable number.
• The subscription agreement sometimes shows the GP's subscription alongside LPs. Not always.
• The capital account statement, once the deal closes, will reflect the actual capital contributions. This is what an auditor would look at.

If the pitch deck says the GP is investing $1 million and the operating agreement says $500,000, the operating agreement wins. Always cross-check. Our walkthrough of how to read a PPM covers where these provisions sit in the document.

The class of equity

Read the class structure in the operating agreement. The GP's capital should be in the same class as LP capital, or in a class that is pari passu. If the GP's equity has different rights — priority distributions, different waterfall treatment, or a carve-out from clawback obligations — the alignment is weaker than the headline suggests.

Common patterns to watch for:

• GP equity structured as preferred with a priority return ahead of LPs
• GP equity that is not subject to the same promote calculation (the GP effectively gets their own capital back without paying themselves promote on it, which is fine, but some structures also exempt GP capital from LP waterfall protections)
• GP equity with enhanced redemption rights that LP equity does not have

The fee stack comparison

Co-investment is not a standalone number — it has to be read alongside the fee structure. A sponsor with a 5% co-invest and a reasonable fee load is very different from a sponsor with a 5% co-invest and a fee stack that returns more to the GP in the first 18 months than their entire co-investment.

A useful mental exercise: add up every fee the GP will earn in year one (acquisition, asset management, construction management, loan guaranty, any sponsor-related debt placement). Compare that number to the co-investment. If the year-one fee income exceeds the co-investment, the sponsor has de-risked themselves before the deal has even proven out its business plan.

Edge Cases Worth Understanding

The fund-of-funds sponsor

If you are investing through a fund-of-funds, the question gets one layer more complex. The fund sponsor invests in underlying syndications, and each of those underlying syndications has its own GP co-invest. You need to ask two questions:

1. How much does the fund sponsor invest personally in the fund itself?
2. Do the underlying deals the fund invests in have meaningful GP co-investment?

A fund-of-funds sponsor with strong personal investment in their own fund is useful. But if they are allocating that capital to underlying deals where the GPs have no skin in the game, the alignment chain breaks at the second link.

The "family office" framing

Some sponsors describe their co-investment as coming from "the family office" or "aligned capital." This language sometimes describes a structure where multiple family members, trusts, or related entities are pooling capital. That is fine. But occasionally it describes a structure where the co-investment is technically from the sponsor's family but held in a way that does not expose the individual principals to real downside.

The clarifying question is: if this deal goes to zero, does the individual running it lose personal capital? If the answer is yes, the family-office framing is real. If the answer is "the family is protected through the structure," the co-investment is mostly cosmetic.

Development deals and the equity contribution timing

In ground-up development, GPs sometimes commit to a capital contribution that is funded later in the construction timeline rather than at closing. The operating agreement might specify a $1 million GP commitment that is drawn down over 18 months as construction progresses.

This is defensible if the draw schedule matches the deal's capital needs. It becomes problematic if the GP's contribution is effectively last-in-last-out — meaning LP capital is called and deployed first, and the GP commitment only funds if the deal hits certain milestones. If the deal runs into trouble before those milestones, the GP may never actually fund their portion.

A Short Framework for Your Next Deal

When you receive the next offering document, pull out a sheet of paper and fill in these five lines:

1. Stated GP co-investment (dollars and percentage of equity raise): _________
2. Portion that is personal after-tax capital (not waived or deferred fees): _________
3. Year-one fee income to the GP: _________
4. Class of equity (same as LPs, subordinate, or senior/preferred): _________
5. Sponsor-provided answer to "what percentage of your current liquid capital is this?": _________

If line 2 is less than 3% of equity raised, or if line 3 exceeds line 2, the co-investment is not doing the alignment work it appears to do. That does not kill the deal. It just means the alignment has to come from somewhere else — an aggressive clawback, deeply subordinated fees, a heavy LP-favorable waterfall, or a long track record of treating LPs well in drawdowns.

If you cannot get clean answers to these five questions, that is itself the answer. Sponsors who have genuinely structured their economics to win with their investors are comfortable being specific. Sponsors who have not will steer the conversation back to projected returns and market tailwinds.

The Bottom Line

Co-investment is the only alignment signal that is verifiable in advance, before the deal has had a chance to go well or badly. The projected returns are assumptions. The track record is history. The GP's incentive structure during the hold period is shaped, more than anything else, by how much of their own capital is sitting in the deal on the same terms as yours.

A 5% rule of thumb is a useful starting point, but the more important test is whether the number represents real personal capital, priced the same as your capital, with no exits the LPs do not also have. When it does, the alignment conversation mostly takes care of itself. When it does not, no other provision in the operating agreement can fully compensate.

If you are early in your LP journey, pair this post with our walkthrough on how to evaluate a real estate syndication sponsor and our guide to the LP due diligence process. Co-investment is the single cleanest filter, but it works best as one input among several.